Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIH subunit 2B (GTF2H2B) is annotated as a pseudogene in the human genome. It does not encode a functional protein and does not participate in biological processes or act as a receptor, enzyme, transporter, or therapeutic target. It should not be confused with the closely related functional gene "General transcription factor IIH subunit 2" (GTF2H2), which is a component of the TFIIH complex essential for transcription initiation and DNA repair[1][13]. No drug interactions, disease roles, or diagnostic utility are reported for GTF2H2B. The entry is sometimes found in gene databases (with alias DKFZP686M0199), but it does not meet criteria for being considered a therapeutic target or biologically active molecule[3][5][7][9][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIH subunit 2B (pseudogene) (GTF2H2B).